Ziebart, T <br/><br/>
Geranylgeraniol - a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw.  [electronic resource] 

 -  Oral oncology  Mar 2011 
 - 195-201 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0593 
<br/><br/><label>Standard No.: </label>10.1016/j.oraloncology.2010.12.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bone Density Conservation Agents--adverse effects<br/>Diphosphonates--adverse effects<br/>Diterpenes--pharmacology<br/>Endothelial Cells--drug effects<br/>Fibroblasts--drug effects<br/>Humans<br/>In Vitro Techniques<br/>Jaw Diseases--chemically induced<br/>Osteoblasts--drug effects<br/>Osteonecrosis--chemically induced